Sharing Data to Accelerate Medicine Development and Improve Neonatal Care: Data Standards and Harmonized Definitions

The development and testing of the majority of medicine prescribed for newborn infants has been inadequate, with multiple barriers despite multiple legislative initiatives to encourage studies.1 One impediment is our current limited capacity to share standardized data that would facilitate the evaluation of the effectiveness and risks of medicine given to newborn infants. Neonatal drug development requires data sharing2-4 and in this commentary, we will discuss the importance and feasibility of defining standards for definitions when sharing neonatal data in a context that meets the needs of multiple stakeholders.

https://ift.tt/2RoTh2J